Replimune
Price & Volume
Stats
See more52W Range | $6.44-$17 |
Market Cap | $845.6M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.07 |
News
See moreYahoo Finance • 4 days ago
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 8 days ago
H.C. Wainwright reiterates Buy rating on Replimune stock ahead of FDA decision
Yahoo Finance • 9 days ago
Replimune's SWOT analysis: oncology firm's stock poised for FDA decision
Yahoo Finance • 25 days ago
Cantor Fitzgerald initiates Replimune stock with overweight rating
About
CEO | Dr. Sushil Patel Ph.D. |
Address | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 479 |
